-
公开(公告)号：US20240101697A1
公开(公告)日：2024-03-28
申请号：US18208361
申请日：2023-06-12
Applicant: Janssen Biotech, Inc. , Stichting VUmc
Inventor： Homer Adams , Francois Gaudet , Niels Van de Donk , Kris Frerichs , Christie Verkleij
CPC classification number: C07K16/2896 , A61K45/06 , A61P35/00 , A61P35/02 , C07K16/2809 , C07K16/2878 , C07K16/30 , C07K16/468 , A61K2039/505 , C07K2317/21 , C07K2317/31
Abstract: Disclosed are methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics.
-
公开(公告)号：US20160067205A1
公开(公告)日：2016-03-10
申请号：US14847428
申请日：2015-09-08
Applicant: Janssen Biotech, Inc.
Inventor： Henk M. Lokhorst , Tuna Mutis , Inger S Nijhof , Niels Van de Donk
IPC: A61K31/203 , A61K39/395 , C07K16/40
CPC classification number: C07K16/2896 , A61K31/203 , A61K39/39558 , A61K2039/505 , A61P35/00 , C07K2317/34 , C07K2317/51 , C07K2317/56 , C07K2317/565 , C07K2317/732 , C07K2317/734 , C07K2317/92 , A61K2300/00
Abstract: The present invention relates to combination therapies with anti-CD38 antibodies and all-trans retinoic acid.
Abstract translation: 本发明涉及与抗CD38抗体和全反式视黄酸的组合疗法。
-
公开(公告)号：US12012461B2
公开(公告)日：2024-06-18
申请号：US16412831
申请日：2019-05-15
Applicant: Janssen Biotech, Inc. , Stichting VUmc
Inventor： Homer Adams , Francois Gaudet , Niels Van de Donk , Kris Frerichs , Christie Verkleij
CPC classification number: C07K16/2896 , A61K45/06 , A61P35/00 , A61P35/02 , C07K16/2809 , C07K16/2878 , C07K16/30 , C07K16/468 , A61K2039/505 , C07K2317/21 , C07K2317/24 , C07K2317/31 , C07K2317/565 , C07K2317/71
Abstract: Disclosed are methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics.
-
Patent Agency Ranking
公开(公告)号：US20170107295A1
公开(公告)日：2017-04-20
申请号：US15386391
申请日：2016-12-21
Applicant: Janssen Biotech, Inc.
Inventor： Henk M. Lokhorst , Tuna Mutis , Inger S Nijhof , Niels Van de Donk
IPC: C07K16/28 , A61K39/395 , A61K31/203
CPC classification number: C07K16/2896 , A61K31/203 , A61K39/39558 , A61K2039/505 , A61P35/00 , C07K2317/34 , C07K2317/51 , C07K2317/56 , C07K2317/565 , C07K2317/732 , C07K2317/734 , C07K2317/92 , A61K2300/00
Abstract: The present invention relates to combination therapies with anti-CD38 antibodies and all-trans retinoic acid.
-
公开(公告)号：US20240301083A1
公开(公告)日：2024-09-12
申请号：US18657180
申请日：2024-05-07
Applicant: Janssen Biotech, Inc. , Stichting VUmc
Inventor： Homer Adams , Francois Gaudet , Niels Van de Donk , Kris Frerichs , Christie Verkleij
CPC classification number: C07K16/2896 , A61K45/06 , A61P35/00 , A61P35/02 , C07K16/2809 , C07K16/2878 , C07K16/30 , C07K16/468 , A61K2039/505 , C07K2317/21 , C07K2317/24 , C07K2317/31 , C07K2317/565 , C07K2317/71
Abstract: Disclosed are methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics.
-
公开(公告)号：US12065500B2
公开(公告)日：2024-08-20
申请号：US16412701
申请日：2019-05-15
Applicant: Janssen Biotech, Inc. , Stichting VUmc
Inventor： Homer Adams , Francois Gaudet , Niels Van de Donk , Kris Frerichs , Christie Verkleij
CPC classification number: C07K16/2896 , A61K45/06 , A61P35/00 , A61P35/02 , C07K16/2809 , C07K16/2878 , C07K16/30 , C07K16/468 , A61K2039/505 , C07K2317/21 , C07K2317/24 , C07K2317/31 , C07K2317/565 , C07K2317/71
Abstract: Disclosed are methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics.
-
公开(公告)号：US10604580B2
公开(公告)日：2020-03-31
申请号：US15386391
申请日：2016-12-21
Applicant: Janssen Biotech, Inc.
Inventor： Henk M. Lokhorst , Tuna Mutis , Inger S Nijhof , Niels Van de Donk
IPC: A61K39/395 , C07K16/28 , A61K31/203 , A61P35/00 , A61K39/00
Abstract: The present invention relates to combination therapies with anti-CD38 antibodies and all-trans retinoic acid.
-
公开(公告)号：US20190352421A1
公开(公告)日：2019-11-21
申请号：US16412701
申请日：2019-05-15
Applicant: Janssen Biotech, Inc. , Stitching VUmc
Inventor： Homer Adams , Francois Gaudet , Niels Van de Donk , Kris Frerichs , Christie Verkleij
Abstract: Disclosed are methods of treating cancers and enhancing efficacy of T cell redirecting therapeutics.
-
-
-
-
-
-
-
Search Results
8
records
(took 0.019 seconds)
